ArticleMolecular therapy oncolytics2020

lncRNA DUXAP8 Facilitates Multiple Malignant Phenotypes and Resistance to PARP Inhibitor in HCC via Upregulating FOXM1.

Yu Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.